The Outlook for Vaccines, Variants and Elusive Herd Immunity - Butler Financial, LTD
Why you should maintain a long-term view amid bank headlines - March 17, 2023

Resources

The Outlook for Vaccines, Variants and Elusive Herd Immunity

How do COVID-19 vaccines perform against the delta variant? When is FDA approval expected? And is herd immunity really achievable?

Raymond James Biotechnology Analyst Steve Seedhouse, Ph.D., addresses these questions and more in the latest episode of For What It’s Worth. Hear him discuss the latest data around vaccine effectiveness, the transition from pandemic to possible endemic and how COVID-prompted innovation may open the door for the prevention of other illnesses.

  
Listen to For What It's Worth on Spotify

Recorded August 3, 2021.


Other posts you might like
ButlerFinancial
Spend your retirement thriving

Retirement & Longevity How to make your retirement rewarding and meaningful. Does the conventional...

read more
ButlerFinancial
Favorable current strategy – yield and duration

Markets & Investing March 27, 2023 Doug Drabik discusses fixed income market conditions and offers...

read more
ButlerFinancial
Weekly market guide

Markets & Investing March 24, 2023 Review the latest portfolio strategy commentary from Mike Gibbs,...

read more